Skip to main content

Military Health System

Myths & facts about the vax - debunking common COVID-19 vaccine myths

Image of Myths and facts about the vax. The COVID-19 vaccine has been mandated across the Department of Defense and despite its demonstrated effectiveness and safety, a host of myths have left some Airmen and Guardians hesitant to receive it. While social media posts and some news outlets may make it harder to keep up with what is fact or fiction, the science is clear … approved COVID-19 vaccines work (Photo by: U.S. Air Force).

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus & the MHS Response | COVID-19 Vaccine Efforts

The COVID-19 vaccine has been mandated across the Department of Defense and despite its demonstrated effectiveness and safety, a host of myths have left some Airmen and Guardians hesitant to receive it. While social media posts and some news outlets may make it harder to keep up with what is fact or fiction, the science is clear...approved COVID-19 vaccines work.

Here is a breakdown of the most common myths surrounding COVID-19 vaccines, and the facts behind each myth:

 

Myth: COMIRNATY is not the same as the PFIZER-BIONTECH COVID-19 vaccine.

Truth: It is common for vaccine names to change after receiving full Food and Drug Administration approval for branding purposes. COMIRNATY and Pfizer-BioNTech are biologically and chemically the same vaccine. The FDA approved Pfizer-BioNTech for licensing and branding as COMIRNATY August 23 for people 16 years and older. Critically, the Emergency Use Authorization for Pfizer-BioNTech COVID-19 vaccine continues and covers the 12-15 year old population.

In accordance with FDA guidance, COMIRNATY has the same formulation and can be used interchangeably with the FDA-authorized Pfizer-BioNTech COVID-19 vaccine. Providers can use doses distributed under the EUA, to administer the vaccination series as if the doses were the licensed vaccine.

Myth: There were no people of color involved or represented in the research or development of the vaccine.

Truth: COVID-19 has taken a heavy and disproportionate toll on people of color, particularly Black adults. Historically, people of color have been underrepresented in clinical trials. Therefore, ensuring racial and ethnic diversity in clinical trials for development of COVID-19 vaccines has been particularly important. Diversity within clinical trials for a COVID-19 vaccine also ensures safety and effectiveness across populations. Findings show that Pfizer-BioNTech vaccine safety and efficacy were similar for people of color and white participants.

The FDA offered nonbinding recommendations that strongly encouraged the enrollment of populations most affected by COVID-19, specifically racial and ethnic minorities. Both Pfizer and Moderna worked to ensure that people of color were included in their trials, with Moderna even slowing down enrollment to enroll more racial and ethnic minorities. There have also been efforts on the community side. Historically Black colleges and universities participated in COVID-19 vaccine trials and encouraged participation among their communities. The purposeful encouragement to increase racial and ethnic groups in these trials have achieved greater diversity than many previous trials for other drugs.

Myth: The COVID-19 vaccine can cause problems with breast tissue and lead to breast cancer.

Truth: There is no evidence that COVID-19 vaccines cause problems with breast tissue or would lead to breast cancer. The mRNA vaccines are processed by your body near the injection site and activate immune system cells that then travel through the lymph system to nearby lymph nodes. In this manner, an individual may experience swelling under the arm where the vaccine was administered due to swelling of the lymph node. The vaccines are not affecting hormone levels, nor are they traveling throughout the body or affecting other body organs, such as breast tissue. Swollen lymph nodes can show up in a mammogram even if women can't feel them. Hence, the Society of Breast Imaging recommends women delay any routine mammography scheduled within four weeks after their most recent COVID-19 vaccination.

Military health personnel filling a syringe with the COVID-19 vaccine
Air Force Master Sgt. Luca Farkas, 911th Aeromedical Staging Squadron aeromedical technician, fills a syringe with the COVID-19 vaccine at the Pittsburgh International Airport Air Reserve Station, Pennsylvania in Jan. 2021 (Photo by: Joshua Seybert, 911th Airlift Wing). 

Myth: If I take COMIRNATY while breastfeeding, my baby will be infected with COVID-19.

Truth: COVID-19 vaccines cannot cause infection in anyone. Vaccines are effective at preventing COVID-19 in people who are breastfeeding. Additionally, breastfeeding people who have received mRNA COVID-19 vaccines have antibodies in their breast milk, which could help protect their babies. The Centers for Disease Control and Prevention and the Academy of Breastfeeding Medicine recommend that lactating women receive the vaccine and that breastfeeding should not be stopped around the period of vaccination.

Myth: COVID-19 causes infertility.

Truth: There is no evidence that COVID-19 vaccines cause fertility problems in women or men. The mRNA vaccines are processed by your body near the injection site and activate immune system cells that then travel through the lymph system to nearby lymph nodes. In this manner, they are not affecting hormone levels, nor are they traveling throughout the body or affecting other body organs.

Myth: The Vaccine Adverse Event Reporting System proves that COVID-19 vaccination causes too many side effects and deaths.

Truth: VAERS data alone cannot determine if an adverse event was caused by a COVID-19 vaccination. Anyone can report individual events to VAERS, even if it is not clear whether a vaccine caused the problem. These events are studied by vaccine safety experts who track for trends, then validate significant adverse concerns. Recently, the number of deaths reported in VAERS has been misinterpreted and misreported as if this number means deaths were proven to be caused by COVID-19 vaccination.

Myth: COMIRNATY vaccine contains fetal cells.

Truth: None of the COVID-19 vaccines contain fetal cells. Specifically, COMIRNATY and Moderna COVID-19 vaccines did not use a fetal cell line to manufacture their vaccine. However, a fetal cell line was used in early research efficacy of these vaccines.

The use of these fetal cell lines in research and/or production of vaccines and medication is not new. Some over-the-counter medications for which a historic fetal cell line was utilized in research and/or production and manufacturing include: Tylenol, Pepto Bismol, Aspirin, Tums, Senokot, Motrin, Maalox, Ex-Lax, Benadryl, Sudafed, Preparation H, Claritin, and others.

Military personnel receiving the COVID-19 vaccine
Air Force Master Sgt. Tiffany Sneeze, from the 165th Airlift Wing, administers the COVID-19 vaccination to an Airman in June 2021 on Dobbins Air Force Base, Georgia (Photo by: Army Capt. Amanda Russell, Georgia National Guard).

Myth: Researchers rushed the development of the COVID-19 vaccine, so its effectiveness and safety cannot be trusted.

Truth: The COVID-19 vaccines in the U.S. have gone through the typical FDA approval process - no steps were skipped - but some steps were conducted on an overlapping schedule to gather data faster.

First, the COVID-19 vaccines from Pfizer-BioNTech and Moderna were created with a method that has been in development for years, so the companies could start the vaccine development process early in the pandemic. Second, vaccine projects received large resources. Governments invested in research and/or paid for vaccines in advance, which enabled a faster approach. Third, some types of COVID-19 vaccines were created using messenger RNA (mRNA), which allows a faster approach than the traditional way that vaccines are made. Fourth, the capabilities of social media reaching numerous people enabled companies to find and engage study volunteers at a faster than typical pace. Finally, COVID-19 is so contagious and widespread, therefore it did not take long to see if the vaccine worked for the study volunteers who were vaccinated.

Myth: If I get the COVID-19 vaccine, it will make me sick with COVID-19.

Truth: You cannot get COVID-19 disease from the COVID-19 vaccine. COVID-19 vaccines teach our immune systems how to recognize and fight the virus that causes COVID-19. Sometimes this process can cause symptoms, such as fever. These symptoms are normal and are signs that the body is building protection against the virus that causes COVID-19. If you do not have side effects, that does not mean your body's immune system is not responding.

Myth: COVID-19 vaccines shed or release their components and are harmful.

Truth: Vaccine shedding is the term used to describe the release or discharge of any of the vaccine components in or outside of the body. Vaccine shedding can only occur when a vaccine contains a weakened live version of the virus. None of the COVID-19 vaccines authorized for use in the U.S. contain a live virus.

Myth: COVID-19 vaccine will alter my DNA.

Truth: COVID-19 vaccines do not change or interact with DNA in any way. Both mRNA and viral vector COVID-19 vaccines deliver instructions (genetic material) to our cells to start building protection against the virus that causes COVID-19. However, the material never enters the nucleus of the cell, which is where our DNA resides.

Myth: Receiving the COVID-19 vaccine will make me magnetic.

Truth: All COVID-19 vaccines are free from metals and will not make anyone magnetic. None of the COVID-19 vaccines contain eggs, gelatin, latex, or preservatives.

Myth: The COVID-19 vaccine contains microchips.

Truth: COVID-19 vaccines do not contain manufactured electronic or microchips. Vaccines are developed to fight against disease and are not administered to track your movement. Vaccines work by stimulating your immune system to produce antibodies. After getting vaccinated, you develop immunity to that disease, without having to get the disease first.

 

Airmen, Guardians and family members who still have questions and concerns are encouraged to reach out to their primary care provider. Additional information, including the DOD mandate, can be found here.

You also may be interested in...

Memorandum on Providing Federal Support for Governors' Use of the National Guard to Respond to COVID-19

Publication
4/14/2020

Recommended Content:

Coronavirus & the MHS Response

Stay Home Slide Show

Video
4/10/2020
Stay Home Slide Show

Slide show of photos from BAMC's #stayhome campaign

Recommended Content:

Coronavirus & the MHS Response | Coronavirus and the COVID-19 Vaccine

Delegation of Authority for Reserve Component Activation Authorities during the Coronavirus Disease 2019 Response

Publication
4/10/2020

This delegation assigns to the Service Secretaries the authority to activate Reserve Component personnel and to modify their orders as needed to employ and retain them for the COVID-19 response.

Recommended Content:

Coronavirus & the MHS Response

Authorization to Employ Military Medical Capabilities to Treat COVID-19 Patients

Publication
4/8/2020

Effective immediately, the Commander, U.S Northern Command, is authorized, as he deems necessary and appropriate, to employ military medical capabilities under his operational control to treat patients who have contracted coronavirus disease 2019 (COVID-19).

Recommended Content:

Coronavirus & the MHS Response

Decision Memorandum on TRICARE Implementation of the "Families First Coronavirus Response Act"

Publication
4/7/2020

The Families First Coronavirus Response Act, Public Law 116-127, Division F, Section 6006(a), limits TRICARE authority to impose copayment or other cost-sharing for novel coronavirus (COVID-19) testing and related provider visits that result in orders for or administration of Food and Drug Administration (FDA) approved, cleared, or authorized diagnostic products. In order for the Defense Health Agency (DHA) to implement, the Assistant Secretary of Defense for Health Affairs (ASD(HA)) must acknowledge the self-executing authority of the statute and direct the Director, DHA, or designee, to issue guidance implementing the statutory provisions.

Recommended Content:

Information for Patients: About TRICARE | Coronavirus & the MHS Response

DoD Guidance on the Use of Cloth Face Coverings

Publication
4/5/2020

Effective immediately, to the extent practical, all individuals on DoD property, installations, and facilities will wear cloth face coverings when they cannot maintain six feet of social distance in public areas or work centers (this does not include in a Service member's or Service family member's personal residence on a military installation).

Recommended Content:

Coronavirus & the MHS Response | Public Health

Policy on Accessions and Accessions Training during the COVID-19 Outbreak

Publication
4/3/2020

The Military Departments must seek ways to maximize accessions in a responsible manner to minimize a reduction in military end strength and the potential deterioration of mid-and long-term readiness and capacity.

Recommended Content:

Coronavirus & the MHS Response

Transition of Military Medical Treatment Facilities from Military Departments to the Defense Health Agency during the COVID-19 Response

Publication
4/2/2020

The Department's MTF transition plan is conditions-based. While the transition of MTFs to DHA is continuing, the COVID-19 response requirements are impacting DHA's ability to meet all required conditions. The need for the DHA and MILDEPs to refocus efforts away from the transition to support the COVID-19 response led to questions regarding the future of MTF Transition.

Recommended Content:

Coronavirus & the MHS Response | Military Health System Transformation

Tiered Telehealth Health Care Support for COVID-19

Publication
3/31/2020

This memorandum establishes guidance for the use of Telehealth (TH) Information Technology (IT) tools in support of the clinical care required for patients across the spectrum of COVID-19 illness

Recommended Content:

Information for Patients: About TRICARE | Public Health | Coronavirus & the MHS Response

Pharmacy Guidance for Market MTFs

Publication
3/31/2020

Message to Pharmacy Beneficiaries regarding military pharmacy services during the COVID-19 pandemic.

Recommended Content:

Coronavirus & the MHS Response | TRICARE Pharmacy Operations | Information for Patients: About TRICARE

MHS Minute Combatting COVID 19

Video
3/30/2020
MHS Minute Combatting COVID 19

Agencies across the federal government are partnering up to combat COVID-19. Find out how the Military Health System is doing its part to support the U.S. response to this pandemic, while ensuring our Service members remain ready.

Recommended Content:

Coronavirus & the MHS Response | Coronavirus and the COVID-19 Vaccine

Q & A: Policy Exception for Telehealth Use for ABA during COVID-19 Pandemic

Publication
3/30/2020

Question and Answer: TRICARE Autism Care Demonstration (ACD): Regarding Temporary Authorization to Utilize Telehealth for CPT Code 97156 during the COVID-19 National Emergency

Recommended Content:

Coronavirus & the MHS Response | Information for Patients: About TRICARE

Policy Exception for Telehealth Use for ABA during COVID-19 Pandemic

Publication
3/30/2020

Communication to ABA Providers Regarding Temporary Authorization to Utilize Telehealth for CPT Code 97156 During the COVID-19 National Emergency

Recommended Content:

Coronavirus & the MHS Response | Information for Patients: About TRICARE

COVID-19 Life Support Training Extension

Publication
3/19/2020

The purpose of this memorandum is to set policy guidance within the Military Health System for American Red Cross life support training (First Aid/cardiopulmonary resuscitation (CPR)/automated external defibrillator (AED), Basic Life Support (BLS), Advanced Life Support (ALS), and Pediatric Advanced Life Support (PALS)).

Recommended Content:

Coronavirus & the MHS Response

Terry M. Rauch, Ph.D., M.P.H., M.B.A. Acting Deputy Assistant Secretary of Defense Force Health Protection and Readiness Regarding U.S. Biodefense and Response to the Novel Coronavirus Outbreak [Testified] Before the House Committee on Oversight and Reform

Congressional Testimony
3/11/2020

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine | Coronavirus & the MHS Response
<< < ... 31 32 > >> 
Showing results 451 - 465 Page 31 of 32
Refine your search
Last Updated: September 29, 2021
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery